| 1.82 -0.41 (-18.39%) | 06-30 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.06 |
1-year : | 5.25 |
| Resists | First : | 3.47 |
Second : | 4.5 |
| Pivot price | 2.34 |
|||
| Supports | First : | 1.82 |
Second : | 1.51 |
| MAs | MA(5) : | 2.21 |
MA(20) : | 2.45 |
| MA(100) : | 2.41 |
MA(250) : | 6.01 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 10 |
D(3) : | 15.8 |
| RSI | RSI(14): 32 |
|||
| 52-week | High : | 17.18 | Low : | 1.64 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ZJYL ] has closed below the lower bollinger band by 32.8%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ ZJYL ] is to continue within current trading range. Bollinger Bands are 10.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.35 - 2.36 | 2.36 - 2.37 |
| Low: | 2.15 - 2.17 | 2.17 - 2.18 |
| Close: | 2.21 - 2.23 | 2.23 - 2.25 |
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
Tue, 30 Jun 2026
Massive share issuance and control shift at Jin Medical (ZJYL) with Tongsheng VIE deal - Stock Titan
Mon, 29 Jun 2026
Enterprise value to revenue forward of JIN MEDICAL INTERNATIONAL LTD. – NASDAQ:ZJYL - TradingView
Sun, 21 Jun 2026
JIN MEDICAL INTERNATIONAL (ZJYL) Edges Higher as Stock Approaches Key Resistance - Pullback Trade - dars.gov.et
Wed, 17 Jun 2026
Jin Medical International Ltd (ZJYL) Institutional Confidence - TradingKey
Wed, 17 Jun 2026
Jin Medical International Ltd (ZJYL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Thu, 04 Jun 2026
Jin Medical (ZJYL) appoints Enrome LLP as new independent auditor - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 7 (M) |
| Shares Float | 39 (M) |
| Held by Insiders | 86.9 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 19 (K) |
| Shares Short P.Month | 13 (K) |
| EPS | 0.2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.78 |
| Profit Margin | 5.7 % |
| Operating Margin | 9.8 % |
| Return on Assets (ttm) | 0.7 % |
| Return on Equity (ttm) | 4.7 % |
| Qtrly Rev. Growth | -16.5 % |
| Gross Profit (p.s.) | 0.91 |
| Sales Per Share | 3.02 |
| EBITDA (p.s.) | 0.12 |
| Qtrly Earnings Growth | -32 % |
| Operating Cash Flow | 3 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | 9.1 |
| PEG Ratio | 0 |
| Price to Book value | 0.48 |
| Price to Sales | 0.6 |
| Price to Cash Flow | 4.28 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |